Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia
Achondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can e...
Main Authors: | , |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Rare Diseases
2023-10-01
|
Series: | 罕见病研究 |
Subjects: | |
Online Access: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004 |
_version_ | 1797370243913351168 |
---|---|
author | LIU Fuze WANG Hai |
author_facet | LIU Fuze WANG Hai |
author_sort | LIU Fuze |
collection | DOAJ |
description | Achondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can exacerbate spinal stenosis, leading to neurological complications. This paper provides a brief review of the pathophysiological mechanisms, clinical characteristics, and treatments for spinal stenosis and TLK in ACH patients. Recently, three new drugs targeting FGFR3; vosoritide, recifercept, and infigratinib, have completed or are undergoing clinical trials. They have shown promising preliminary results in preventing spinal stenosis and TLK. |
first_indexed | 2024-03-08T17:58:36Z |
format | Article |
id | doaj.art-c0f2fcceaa624ddbbf87c287cd4fb951 |
institution | Directory Open Access Journal |
issn | 2097-0501 |
language | zho |
last_indexed | 2024-03-08T17:58:36Z |
publishDate | 2023-10-01 |
publisher | Editorial Office of Journal of Rare Diseases |
record_format | Article |
series | 罕见病研究 |
spelling | doaj.art-c0f2fcceaa624ddbbf87c287cd4fb9512024-01-02T03:18:14ZzhoEditorial Office of Journal of Rare Diseases罕见病研究2097-05012023-10-012448349110.12376/j.issn.2097-0501.2023.04.004Spinal Stenosis and Thoracolumbar Kyphosis in AchondroplasiaLIU FuzeWANG HaiAchondroplasia (ACH) is a rare autosomal-dominant genetic disease resulting from a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. It is characterized by asymmetric short stature. Spinal stenosis and thoracolumbar kyphosis (TLK) are common findings in ACH patients. Severe TLK can exacerbate spinal stenosis, leading to neurological complications. This paper provides a brief review of the pathophysiological mechanisms, clinical characteristics, and treatments for spinal stenosis and TLK in ACH patients. Recently, three new drugs targeting FGFR3; vosoritide, recifercept, and infigratinib, have completed or are undergoing clinical trials. They have shown promising preliminary results in preventing spinal stenosis and TLK.https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004spinal stenosisthoracolumbar kyphosisachondroplasiafibroblast growth factor receptor-3 |
spellingShingle | LIU Fuze WANG Hai Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia 罕见病研究 spinal stenosis thoracolumbar kyphosis achondroplasia fibroblast growth factor receptor-3 |
title | Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia |
title_full | Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia |
title_fullStr | Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia |
title_full_unstemmed | Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia |
title_short | Spinal Stenosis and Thoracolumbar Kyphosis in Achondroplasia |
title_sort | spinal stenosis and thoracolumbar kyphosis in achondroplasia |
topic | spinal stenosis thoracolumbar kyphosis achondroplasia fibroblast growth factor receptor-3 |
url | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2023.04.004 |
work_keys_str_mv | AT liufuze spinalstenosisandthoracolumbarkyphosisinachondroplasia AT wanghai spinalstenosisandthoracolumbarkyphosisinachondroplasia |